Cumulative incidence of second malignant neoplasms after childhood leukemia and lymphoma: an international study. An international study

Jón Gunnlaugur Jónasson, Milena Maule, G Scélo, Franco Merletti, P Brennan, Kari Hemminki, E Tracey, E. Pukkala, Elisabete Weiderpass, J H Olsen, M. L. McBride, D H Brewster, Vera Pompe-Kirn, E V Kliewer, Kee-Seng Chia, Jon M. Tonita, C Martos, Guido Pastore, Paolo Boffetta, Risto Sankila

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Survivors of childhood leukemia and lymphoma experience high risks of second malignant neoplasms. We quantified such risk using a large dataset from 13 population-based cancer registries. Methods: The registries provided individual data on cases of leukemia, Hodgkin lymphoma, and non-Hodgkin lymphoma occurring in children aged 0-14 years and on subsequent second malignant neoplasms for different time periods from 1943 to 2000. Risks of second malignant neoplasms were assessed through standardized incidence ratios (SIRs) and corresponding 95% confidence intervals (CIs), using the incidence rates in the general populations covered by the registries as a reference. Cumulative absolute risks were also calculated. Results: A total of 133 second malignant neoplasms were observed in 16 540 patients (12 731 leukemias, 1246 Hodgkin lymphomas, and 2563 non-Hodgkin lymphomas) after an average follow-up of 6.5 years. The most frequent second malignancies after leukemia were brain cancer (19 cases, SIR = 8.52, 95% CI = 5.13 to 13.3), non-Hodgkin lymphoma (nine cases, SIR = 9.41, 95% CI = 4.30 to 17.9), and thyroid cancer (nine cases, SIR = 18.8, 95% CI = 8.60 to 35.7); the most frequent after Hodgkin lymphoma were thyroid cancer (nine cases, SIR = 52.5, 95% CI = 24.0 to 99.6), breast cancer (six cases, SIR = 20.9, 95% CI = 7.66 to 45.4), and neoplasms of skin (non-melanoma) (six cases, SIR = 34.0, 95% CI = 12.5 to 74.0); and the most frequent after non-Hodgkin lymphoma were thyroid cancer (six cases, SIR = 40.4, 95% CI = 14.8 to 88.0) and brain cancer (four cases, SIR = 6.97, 95% CI = 1.90 to 17.9). Cumulative incidence of any second malignant neoplasm was 2.43% (95% CI = 1.09 to 3.78), 12.7% (95% CI = 8.29 to 17.2), and 2.50% (95% CI = 1.04 to 3.96) within 30 years from diagnosis of leukemia, Hodgkin lymphoma, and non-Hodgkin lymphoma, respectively. Conclusions: This population-based study provides, to our knowledge, the most precise and up-to-date estimates for relative and absolute risks of second malignant neoplasms after childhood leukemia and lymphoma.

Original languageEnglish
Pages (from-to)790-800
Number of pages11
JournalJNCI: Journal of the National Cancer Institute
Volume99
Issue number10
DOIs
Publication statusPublished - 16 May 2007

Fingerprint

Dive into the research topics of 'Cumulative incidence of second malignant neoplasms after childhood leukemia and lymphoma: an international study. An international study'. Together they form a unique fingerprint.

Cite this